San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation ...

Nvidia’s partnership with the gene sequencing company is one of several healthcare collaborations revealed Monday by the ...

Illumina, Inc., a leader in DNA sequencing and array technologies, has launched a pilot proteomics program analyzing 50,000 ...

Illumina (ILMN) announced it is collaborating with Nvidia (NVDA) to advance technology platforms for the analysis and interpretation of ...

Illumina has begun rolling out a series of updates to its top-of-the-line DNA sequencer models, with the goal of making the ...

Illumina raises Q4 and FY24 revenue outlook, expects solid margins, with projected 2024 EPS between $4.12 and $4.14.

Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will ...

The pilot program is based on Illumina's upcoming proteomics assay, Illumina Protein Prep, powered by SOMAmer technology, a next-generation sequencing (NGS) based solution that will help scale access ...

Nvidia Corp. announced tie-ups with Illumina Inc., the Mayo Clinic and other health-care organizations as part of its push to ...

A collection of publications on comparison of high-throughput sequencing technologies.